Triple meeting – Mirati avoids the worst-case scenario

Triple meeting – Mirati avoids the worst-case scenario

Source: 
EP Vantage
snippet: 

Like AMG 510, MRTX849 yields partial responses in some lung and colorectal tumours, but investors could have expected better.